https://publikationen.uni-tuebingen.de/xmlui/handle/10900/107535?show=full
Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo...
acute respiratory distressfor the
https://pubmed.ncbi.nlm.nih.gov/40387381/
Iloprost for the Treatment of Severe Septic Shock with Persistent Hypoperfusion: A Double-Blind,...
https://pubmed.ncbi.nlm.nih.gov/11149275/?dopt=Abstract&holding=idemdclib_fft&otool=idemdclib
[Iloprost as inhalational and intravenous long-term treatment of patients with primary pulmonary...
Follow-up data for 81 consecutive patients with primary pulmonary hypertension (PPH) and pulmonary hypertension related to connective tissue diseases or liver...
long term treatment
https://pubmed.ncbi.nlm.nih.gov/7540526/
Treatment of vasculitic leg ulcers in connective tissue disease with iloprost
Leg ulcers are a recognised manifestation of cutaneous vasculitis in connective tissue diseases (CTDs) including rheumatoid arthritis (RA). Iloprost a stable...
connective tissue diseaseleg ulcerstreatment
https://biblio.ugent.be/publication/535564
Effects of inhaled iloprost on right ventricular contractility and ventricular interdependence in...
effectsiloprost
https://portal.fis.tum.de/en/publications/clinical-effects-of-intravenous-iloprost-in-patients-with-intermi/
Clinical effects of intravenous iloprost in patients with intermittent claudication - Technical...
in patientsintermittent claudicationclinicaleffectsintravenous
https://pubmed.ncbi.nlm.nih.gov/11684817/
Comparison of anti-aggregatory effects of PGI2, PGI3 and iloprost on human and rabbit platelets
In human, prostaglandin I3 (PGI3) is as potent inhibitor of platelet aggregation as prostacyclin (PGI2). However the data on the anti-aggregatiory effect of...